ELAN — Elanco Animal Health Inc

—
NYSE · Health Care · Pharmaceuticals · CIK 1739104 ·
Last close
$25.85
Market Cap
$12.92B
52W High
$27.98
52W Low
$19.40
ADV30
5,161,396
Next earnings
2026-11-06

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 1,265,000,000 720,000,000 84,000,000 18,000,000 13,340,000,000 465,000,000 6,712,000,000
Jun 2026 1,368,000,000 798,000,000 118,000,000 54,000,000 13,561,000,000 530,000,000 6,973,000,000
Mar 2026 1,371,000,000 785,000,000 169,000,000 57,000,000 13,222,000,000 428,000,000 6,722,000,000
Dec 2025 1,144,000,000 589,000,000 19,000,000 -276,000,000 13,358,000,000 545,000,000 6,811,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$617,000,000
Investing CF
$-335,000,000
Financing CF
$-310,000,000
CapEx
$-238,000,000
Dividends Paid
—
Buybacks
$-49,000,000
EPS Diluted TTM
$-0.41
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-2,071,000,000
Inventory
$1,769,000,000
Receivables
$1,152,000,000
ST Investments
—
EBIT TTM
$82,000,000
Pretax Income TTM
$-166,000,000
Interest Exp TTM
$248,000,000
Analysts
13

Yahoo Snapshot (yfinance, live)

Total Revenue
$5,148,000,256
EBITDA
$1,060,000,000
Free Cash Flow
$826,875,008
Enterprise Value
$16,563,265,536
Total Cash
$530,000,000
Total Debt
$4,232,999,936
Shares Out
499,621,830
Trailing EPS
$-0.30
Book Value
$13.19
ROE
-3.0%
ROA
1.6%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 4,715,000,000 252,000,000 -232,000,000 13,358,000,000 6,811,000,000 6,547,000,000 560,000,000
Dec 2024 4,439,000,000 251,000,000 338,000,000 12,614,000,000 6,518,000,000 6,096,000,000 541,000,000
Dec 2023 4,417,000,000 326,000,000 -1,231,000,000 14,362,000,000 8,139,000,000 6,223,000,000 271,000,000
Dec 2022 4,411,000,000 384,000,000 -78,000,000 15,491,000,000 8,202,000,000 7,289,000,000 452,000,000

TTM Snapshot

Revenues TTM
$5,020,000,000
NetIncome TTM
$-199,000,000
OpCashFlow TTM
—
Assets (Latest)
$13,561,000,000
Forward EPS
$1.28

Max Pain — expiry 2027-01-15

max pain strike: $21.00 · spot: $26.70 · call oi: 4,953 · put oi: 1,710
Expected Move to 2027-01-15: ±$3.35 (12.55%) — implied range $23.35 – $30.05 · ATM straddle on $27.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
RDY DR REDDYS LABORATORIES LTD $12.32B $14.79 —
BMRN BIOMARIN PHARMACEUTICAL INC $11.33B $58.51 —
BBIO BridgeBio Pharma, Inc. $14.96B $76.80 —
JAZZ Jazz Pharmaceuticals plc $15.45B $240.71 —
MDGL MADRIGAL PHARMACEUTICALS, INC. $9.80B $421.99 —

News headlines (Yahoo Finance, 1h cache)

Elanco to Participate in Upcoming Investor Conferences
2026-11-18 13:22 · Yahoo
TL Foundation Backs VETmAb BIO's Serial Local Entrepreneurs to Strengthen San Diego's Economic Future
2026-11-17 13:54 · Yahoo
Dimensional U.S. Small Cap ETF (DFAS) Sells Skyworks and Elanco on Nov. 9
2026-11-11 11:03 · Yahoo
Elanco (ELAN) shares skyrocket, what you need to know
2026-11-10 07:09 · Yahoo
Elanco Animal Health: 3 Key Takeaways for Long-Term Investors
2026-11-09 12:02 · Yahoo
Elanco Animal Health (ELAN) Stock Still Looks Cheap Following Its 141% Run
2026-11-08 04:19 · Yahoo
What Just Happened With Elanco Animal Health (ELAN)?
2026-11-07 19:14 · Yahoo
Elanco Animal Health Q3 Earnings Call Highlights
2026-11-07 07:16 · Yahoo
Elanco Animal Health Inc (ELAN) (Q3 2026) Earnings Call Highlights: Revenue Up 11%, Guidance ...
2026-11-07 03:14 · Yahoo
Elanco (ELAN) Q3 2026 Earnings Call Transcript
2026-11-06 18:49 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.